Clinical evaluation of biologically targeted drugs: obstacles and opportunities.
- 1 August 1998
- journal article
- review article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 42 (1) , S3-S21
- https://doi.org/10.1007/s002800051075
Abstract
No abstract availableKeywords
This publication has 142 references indexed in Scilit:
- A survey of telomerase activity in human cancerPublished by Elsevier ,1997
- The DNA structures at the ends of eukaryotic chromosomesEuropean Journal Of Cancer, 1997
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- Telomerase as a Potential Molecular Target to Study G-Quartet PhosphorothioatesAntisense and Nucleic Acid Drug Development, 1996
- Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppressionNature Medicine, 1995
- Clinical application of18F-FUdR in glioma patients ? PET study of nucleic acid metabolismJournal of Neuro-Oncology, 1995
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences, 1994
- Acute changes in glucose uptake after treatment: the effects of carmustine (BCNU) on human glioblastoma multiformeJournal of Neuro-Oncology, 1993
- Telomeres shorten during ageing of human fibroblastsNature, 1990